Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Collapse
Home
»
Analysts
»
Andrea Newkirk
Andrea Newkirk
Stock Analyst at Goldman Sachs
(2.92)
# 1,679
Out of 5,055 analysts
4
Total ratings
100%
Success rate
37.57%
Average return
Main Sectors:
Healthcare
Top Industries:
Health Information Services
Biotechnology
Drug Manufacturers - Specialty & Generic
Stocks Rated by Andrea Newkirk
Stock
Action
Price Target
Current
Upside
Ratings
Updated
SDGR
Schrödinger
Initiates:
Neutral
$19
$17.64
+7.71%
1
Sep 30, 2025
RVMD
Revolution Medicines
Maintains:
Buy
$65
→
$73
$67.75
+7.75%
2
Sep 12, 2025
ALKS
Alkermes
Initiates:
Buy
$43
$29.04
+48.07%
1
Jul 15, 2025
SDGR
Schrödinger
Sep 30, 2025
Initiates:
Neutral
Price Target:
$19
Current: $17.64
Upside:
+7.71%
1 Ratings
View All
RVMD
Revolution Medicines
Sep 12, 2025
Maintains:
Buy
Price Target:
$65
→
$73
Current: $67.75
Upside:
+7.75%
2 Ratings
View All
ALKS
Alkermes
Jul 15, 2025
Initiates:
Buy
Price Target:
$43
Current: $29.04
Upside:
+48.07%
1 Ratings
View All